An overview on the correlation of neurological disorders with cardiovascular disease

被引：46

作者：

Firoz, C. K. ^{[1
]}

Jabir, Nasimudeen R. ^{[1
]}

Khan, Mohd Shahnawaz ^{[2
]}

Mahmoud, Maged ^{[1
]}

Shakil, Shazi ^{[3
]}

Damanhouri, Ghazi A. ^{[1
]}

Zaidi, Syed Kashif ^{[4
]}

Tabrez, Shams ^{[1
]}

Kamal, Mohammad A. ^{[1
]}

机构：

[1] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21589, Saudi Arabia

[2] King Saud Univ, Coll Sci, Dept Biochem, Prot Res Chair, Riyadh 11451, Saudi Arabia

[3] Integral Univ, Dept Bioengn, Lucknow 226026, Uttar Pradesh, India

[4] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah 21589, Saudi Arabia

来源：

SAUDI JOURNAL OF BIOLOGICAL SCIENCES | 2015年 / 22卷 / 01期

关键词：

Neurological disorders; Alzheimer's disease; Parkinson disease; Cardiovascular disease; A beta; Dopamine; alpha-Synuclein; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; OXIDATIVE STRESS; EARLY-ONSET; TYROSINE-HYDROXYLASE; APOLIPOPROTEIN-E; RISK-FACTORS; MITOFUSIN; PROTEIN; AGGREGATION;

D O I：

10.1016/j.sjbs.2014.09.003

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Neurological disorders (NDs) are one of the leading causes of death especially in the developed countries. Among those NDs, Alzheimer's disease (AD) and Parkinson disease (PD) are heading the table. There have been several reports in the scientific literatures which suggest the linkage between cardiovascular disorders (CVDs) and NDs. In the present communication, we have tried to compile NDs (AD and PD) association with CVDs reported in the literature. Based on the available scientific literature, we believe that further comprehensive study needs to be done to elucidate the molecular linking points associated with the above mentioned disorders. (C) 2014 King Saud University. Production and hosting by Elsevier B.V.

引用

页码：19 / 23

页数：5

共 64 条

[1]

ALBERTIFIDANZA A, 1994, EUR J CLIN NUTR, V48, P92

[2] 2012 Alzheimer's disease facts and figures [J].

ALZHEIMERS & DEMENTIA, 2012, 8 (02) :131-168

[3] Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease [J].

Bell, Robert D. ;

Zlokovic, Berislav V. .

ACTA NEUROPATHOLOGICA, 2009, 118 (01) :103-113

[4] Neopterin measurement in clinical diagnosis [J].

Berdowska, A ;

Zwirska-Korczala, K .

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2001, 26 (05) :319-329

[5] Mitochondrial Contagion Induced by Parkin Deficiency in Drosophila Hearts and Its Containment by Suppressing Mitofusin [J].

Bhandari, Poonam ;

Song, Moshi ;

Chen, Yun ;

Burelle, Yan ;

Dorn, Gerald W., II .

CIRCULATION RESEARCH, 2014, 114 (02) :257-265

[6] Protein Phosphatases and Alzheimer's Disease [J].

Braithwaite, Steven P. ;

Stock, Jeffry B. ;

Lombroso, Paul J. ;

Nairn, Angus C. .

PROTEIN PHOSPHORYLATION IN HEALTH AND DISEASE, 2012, 106 :343-379

[7] Shattuck lecture - Cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities [J].

Braunwald, E .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (19) :1360-1369

[8]

Bruggemann N., 1993, GENEREVIEWS

[9] Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins [J].

Casserly, I ;

Topol, E .

LANCET, 2004, 363 (9415) :1139-1146

[10] PINK1-Phosphorylated Mitofusin 2 Is a Parkin Receptor for Culling Damaged Mitochondria [J].

Chen, Yun ;

Dorn, Gerald W., II .

SCIENCE, 2013, 340 (6131) :471-475

← 1 2 3 4 5 6 7 →